MEK (MAPKK) inhibitors. Part 2: structure-activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines.
Zhang N, Wu B, Eudy N, Wang Y, Ye F, Powell D, Wissner A, Feldberg LR, Kim SC, Mallon R, Kovacs ED, Toral-Barza L, Kohler CA.
Zhang N, et al. Among authors: kovacs ed.
Bioorg Med Chem Lett. 2001 Jun 4;11(11):1407-10. doi: 10.1016/s0960-894x(01)00238-4.
Bioorg Med Chem Lett. 2001.
PMID: 11378365